-
Novartis AG et al v. Mylan Pharmaceuticals Inc. et al DC
- 1:16-cv-00289
- D. Del.
- Filed: 04/22/2016
- Closed: 05/02/2019
- Latest Docket Entry: 05/02/2019
- Judge: Leonard P. Stark
- PACER
4
Plaintiffs
2
Defendants
1
Accused
Product
1
Patent-in-Suit
1,106
Days in
Litigation
-
Novartis AG et al v. Mylan Pharmaceuticals Inc. et al DC
- 1:16-cv-00289
- D. Del.
- Filed: 04/22/2016
- Closed: 05/02/2019
- Latest Docket Entry: 05/02/2019
- Judge: Leonard P. Stark
- PACER
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
Patent Information
-
Validity & Enforceability
| Claim | Outcome |
|---|---|
| All challenged claims |
Enforceable and Valid
Entry 28 |
-
Infringement
Mylan Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 0.5 mg fingolimod capsules | US 5,604,229 A | All Asserted Claims |
Infringement
Entry 28
|
Mylan Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 0.5 mg fingolimod capsules | US 5,604,229 A | All Asserted Claims |
Infringement
Entry 28
|